These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32822105)

  • 1. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L; Kilkenny E; Ferasin H
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac biomarkers in hyperthyroid cats.
    Sangster JK; Panciera DL; Abbott JA; Zimmerman KC; Lantis AC
    J Vet Intern Med; 2014; 28(2):465-72. PubMed ID: 24350989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
    Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
    J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.
    Borgeat K; Sherwood K; Payne JR; Luis Fuentes V; Connolly DJ
    J Vet Intern Med; 2014; 28(6):1731-7. PubMed ID: 25319115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.
    Hori Y; Iguchi M; Heishima Y; Yamashita Y; Nakamura K; Hirakawa A; Kitade A; Ibaragi T; Katagi M; Sawada T; Yuki M; Kanno N; Inaba H; Isayama N; Onodera H; Iwasa N; Kino M; Narukawa M; Uchida S
    J Vet Intern Med; 2018 May; 32(3):922-929. PubMed ID: 29660794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
    J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats.
    Singh MK; Cocchiaro MF; Kittleson MD
    J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy.
    Hanås S; Larsson A; Rydén J; Lilliehöök I; Häggström J; Tidholm A; Höglund K; Ljungvall I; Holst BS
    J Feline Med Surg; 2022 Oct; 24(10):e370-e379. PubMed ID: 36073987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    Zhang C; Liu R; Yuan J; Cui J; Hu F; Yang W; Zhang Y; Chen Y; Qiao S
    PLoS One; 2016; 11(1):e0146572. PubMed ID: 26765106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy.
    Rohrbaugh MN; Schober KE; Rhinehart JD; Bonagura JD; Habing A; Yildiz V
    J Vet Intern Med; 2020 May; 34(3):1091-1101. PubMed ID: 32364632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
    Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
    J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin I in cats with hypertrophic cardiomyopathy.
    Connolly DJ; Cannata J; Boswood A; Archer J; Groves EA; Neiger R
    J Feline Med Surg; 2003 Aug; 5(4):209-16. PubMed ID: 12878148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
    Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
    J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.